Science to medicine®
-
When you are diagnosed with a serious disease, life doesn't stop and neither will we.
-
At Regeneron, we are driven by science and motivated by patients, every step of the way.
-
We make it our business to bring innovative thinking to the challenge of discovering and developing new medicines.
-
We know that science can change lives and we know that patients need new and improved treatment options.
LATEST NEWS
APR
1
1
Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients
More »
MAR
30
30
Regeneron and Sanofi to Present Phase 3 Praluent® (alirocumab) Injection Clinical Trial Data at ACC.16
More »
MAR
24
24
Regeneron and Bayer To Jointly Develop Novel Combination Therapy for Eye Diseases
More »
OUR PIPELINE
Striving for new therapies that improve patients' lives
We have an extensive pipeline of investigational product candidates that are progressing through all stages of human clinical trials. Our product candidates address many serious medical conditions including cancer, eye diseases, inflammatory diseases, pain, cardiovascular diseases, and allergic conditions.
OUR PRODUCTS
-
OUR PEOPLE
"Discovering and developing drugs to help patients takes years of hard work. There are no shortcuts in this business, but we always believed that we could succeed."
Leonard Schleifer, MD, PhD, President and CEO
-
OUR PEOPLE
"Regeneron is a place where new ideas are welcome. The environment fosters growth and progress that allows us to produce a product that meets the highest quality standards."
Shazad Suchit, Quality Control Analyst III
-
OUR PEOPLE
"Everything that we’ve been doing for 25 years interconnects. We're building on the foundation of those early ideas and taking them to the next level."
George Yancopoulos, MD, PhD, Founding Scientist, President, Regeneron Laboratories and Chief Scientific Officer
-
OUR PEOPLE
"Our drug development programs are propelled by the desire to address unmet medical needs, and all our work is done with the utmost integrity."
Sumathi Sivapalasingam, Director Clinical Sciences Translational Medicine
OUR PROMISE
Integrity is a core value at Regeneron and lies at the heart of everything we do.
Learn more about our Corporate Responsibility, Ethics and Compliance.
